SAFINAMIDE MESYLATE

SAFINAMIDE MESYLATE was reported 1386 times

SAFINAMIDE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDICAL DEVICE SITE PARAESTHESIA 1 0.2000
1 INFUSION SITE CALCIFICATION 1 0.1111
2 DELAYED LIGHT ADAPTATION 2 0.1000
3 LATEROPULSION 1 0.0833
4 BLOOD PRESSURE DIASTOLIC 1 0.0556
5 DOPAMINE AGONIST WITHDRAWAL SYNDROME 3 0.0556
6 ADMINISTRATION SITE NODULE 3 0.0500
7 DEVICE PRIMING 1 0.0435
8 MEDICAL DEVICE SITE WARMTH 2 0.0426
9 ADJACENT SEGMENT DEGENERATION 1 0.0400
10 REDUCED FACIAL EXPRESSION 36 0.0355
11 INFUSION SITE DERMATITIS 1 0.0345
12 DRUG THERAPEUTIC INCOMPATIBILITY 5 0.0325
13 INFUSION SITE CYST 1 0.0312
14 EXPOSURE TO HOUSEHOLD CHEMICALS 1 0.0294
15 ADMINISTRATION SITE INJURY 1 0.0278
16 HYPERKINESIA 57 0.0269
17 DUPLICATE THERAPY ERROR 8 0.0249
18 INFUSION SITE EROSION 1 0.0244
19 EAR CANAL INJURY 1 0.0244
20 PUNCTURE SITE ERYTHEMA 2 0.0233
21 INSULIN C-PEPTIDE INCREASED 3 0.0216
22 DYSKINESIA HYPERPYREXIA SYNDROME 1 0.0213
23 FREEZING PHENOMENON 78 0.0210
24 ATRIAL APPENDAGE CLOSURE 1 0.0200
25 GASTROSTOMY TUBE REMOVAL 1 0.0200
26 MICROGRAPHIA 1 0.0200
27 INFUSION SITE ABSCESS 10 0.0198
28 DELIRIUM TREMENS 8 0.0198
29 ON AND OFF PHENOMENON 108 0.0194
30 ACTION TREMOR 3 0.0185
31 SALIVA DISCOLOURATION 6 0.0180
32 PARKINSONIAN GAIT 11 0.0176
33 STOMA SITE HYPERGRANULATION 11 0.0174
34 TOE WALKING 2 0.0171
35 DEPENDENT PERSONALITY DISORDER 3 0.0166
36 ORGANIC BRAIN SYNDROME 3 0.0160
37 NEUROPROSTHESIS IMPLANTATION 2 0.0144
38 MEDICAL DEVICE SITE SCAB 1 0.0137
39 EXPULSION OF MEDICATION 7 0.0132
40 BLADDER SPHINCTER ATONY 2 0.0129
41 OPEN GLOBE INJURY 2 0.0121
42 SPEECH SOUND DISORDER 2 0.0116
43 STOMA SITE IRRITATION 6 0.0110
44 MULTIPLE DRUG HYPERSENSITIVITY 1 0.0104
45 POSTURAL TREMOR 3 0.0103
46 INFUSION SITE INFLAMMATION 7 0.0099
47 ACQUIRED CLAW TOE 1 0.0099
48 AKINESIA 20 0.0096
49 INFUSION SITE INDURATION 14 0.0094
50 BRADYKINESIA 54 0.0091
51 STOMA SITE OEDEMA 2 0.0091
52 STOMA SITE ERYTHEMA 17 0.0091
53 STOMA SITE DISCHARGE 24 0.0088
54 INFUSION SITE HAEMATOMA 4 0.0084
55 DEEP BRAIN STIMULATION 5 0.0083
56 VITAMIN B6 DEFICIENCY 2 0.0081
57 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 8 0.0079
58 PATIENT DISSATISFACTION WITH DEVICE 2 0.0079
59 INFUSION SITE PUSTULE 1 0.0078
60 LARYNGEAL ULCERATION 1 0.0077
61 FAT TISSUE DECREASED 3 0.0077
62 STOMA SITE PAIN 11 0.0075
63 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 3 0.0075
64 ASYMPTOMATIC BACTERIURIA 1 0.0074
65 DYSCHROMATOPSIA 6 0.0072
66 AVERSION 2 0.0069
67 ENTERAL NUTRITION 4 0.0069
68 DIAPHRAGMATIC SPASM 1 0.0068
69 STOMA SITE INFLAMMATION 5 0.0067
70 BUTTOCK INJURY 2 0.0066
71 MEDICAL DEVICE SITE DISCHARGE 1 0.0065
72 HEPATIC VEIN OCCLUSION 1 0.0063
73 DEVICE PROGRAMMING ERROR 2 0.0063
74 RESTING TREMOR 4 0.0062
75 BLOOD URIC ACID DECREASED 3 0.0062
76 NERVE CONDUCTION STUDIES ABNORMAL 1 0.0060
77 DYSDIADOCHOKINESIS 1 0.0058
78 MEDICAL DEVICE SITE SWELLING 1 0.0058
79 CATHETER SITE ABSCESS 1 0.0057
80 SUSPICIOUSNESS 4 0.0057
81 INFUSION SITE INJURY 1 0.0057
82 ELECTROMYOGRAM ABNORMAL 1 0.0055
83 JEJUNOSTOMY 1 0.0055
84 INFUSION SITE NODULE 5 0.0052
85 HOUSEBOUND 2 0.0050
86 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
87 INFUSION SITE WARMTH 6 0.0049
88 LENTICULAR OPACITIES 2 0.0046
89 SALIVA ALTERED 4 0.0044
90 PRODUCT RESIDUE PRESENT 24 0.0044
91 NASAL OPERATION 3 0.0044
92 FOLATE DEFICIENCY 5 0.0043
93 MALABSORPTION FROM ADMINISTRATION SITE 1 0.0043
94 MENINGIOMA BENIGN 4 0.0043
95 CEREBRAL MICROANGIOPATHY 1 0.0042
96 MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0041
97 DIET REFUSAL 3 0.0041
98 DYSKINESIA 162 0.0040
99 BRONCHITIS BACTERIAL 3 0.0040
100 INCISION SITE DISCHARGE 1 0.0040
101 INCISION SITE ABSCESS 1 0.0038
102 STOMA SITE INFECTION 5 0.0038
103 HYPERHOMOCYSTEINAEMIA 1 0.0038
104 INFUSION SITE CELLULITIS 2 0.0038
105 PRODUCT CLEANING INADEQUATE 10 0.0037
106 THERAPEUTIC PRODUCT EFFECT VARIABLE 14 0.0036
107 AMAUROSIS 3 0.0036
108 CONTRAINDICATED DRUG PRESCRIBED 1 0.0035
109 MORGANELLA INFECTION 1 0.0034
110 DEVICE MAINTENANCE ISSUE 2 0.0034
111 DEVICE COMPUTER ISSUE 1 0.0033
112 DEVICE ALARM ISSUE 6 0.0033
113 MYOCARDIAL RUPTURE 1 0.0033
114 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
115 NEOPLASM PROSTATE 1 0.0032
116 HYPOKINESIA 45 0.0031
117 ABDOMINAL WALL ABSCESS 2 0.0031
118 GASTROENTERITIS RADIATION 1 0.0030
119 CATHETER SITE IRRITATION 1 0.0030
120 INFLAMMATION OF WOUND 1 0.0030
121 CYSTITIS BACTERIAL 1 0.0030
122 ENTEROSTOMY 1 0.0029
123 PATIENT-DEVICE INCOMPATIBILITY 2 0.0029
124 MUSCLE RIGIDITY 35 0.0029
125 STOMA SITE REACTION 2 0.0029
126 INFUSION SITE DISCHARGE 5 0.0028
127 TRAUMATIC HAEMATOMA 3 0.0028
128 ORTHOSTATIC INTOLERANCE 2 0.0028
129 DENTAL RESTORATION FAILURE 2 0.0028
130 HYPERSEXUALITY 5 0.0027
131 OESOPHAGEAL DISCOMFORT 2 0.0026
132 STOMA SITE HAEMORRHAGE 4 0.0026
133 ADMINISTRATION SITE REACTION 1 0.0026
134 DISEASE RISK FACTOR 1 0.0025
135 MENINGEAL DISORDER 1 0.0025
136 EXCESSIVE GRANULATION TISSUE 2 0.0025
137 DEVICE COLOUR ISSUE 1 0.0025
138 COMPULSIVE SHOPPING 5 0.0024
139 FINE MOTOR SKILL DYSFUNCTION 7 0.0024
140 RESUSCITATION 4 0.0024
141 INTESTINAL PROLAPSE 1 0.0024
142 DEVICE CONNECTION ISSUE 5 0.0024
143 INFUSION SITE REACTION 7 0.0023
144 FRACTURE DISPLACEMENT 1 0.0023
145 BELLIGERENCE 1 0.0023
146 REHABILITATION THERAPY 9 0.0023
147 JOINT SURGERY 1 0.0023
148 HEART VALVE OPERATION 1 0.0023
149 HALLUCINATION, OLFACTORY 1 0.0023
150 FOOD REFUSAL 2 0.0023
151 DOPAMINE DYSREGULATION SYNDROME 1 0.0022
152 DELUSION 34 0.0022
153 CERUMEN IMPACTION 2 0.0022
154 HERNIA PAIN 1 0.0022
155 PNEUMOPERITONEUM 4 0.0022
156 INFUSION SITE ERYTHEMA 18 0.0021
157 HALLUCINATION 159 0.0021
158 BLOOD CHOLESTEROL 1 0.0021
159 INVESTIGATION ABNORMAL 3 0.0021
160 IMMOBILE 9 0.0021
161 HALLUCINATION, VISUAL 43 0.0020
162 FLUID INTAKE REDUCED 10 0.0020
163 CSF TEST ABNORMAL 1 0.0020
164 DEVICE OCCLUSION 28 0.0020
165 GLARE 1 0.0019
166 CONSCIOUSNESS FLUCTUATING 2 0.0019
167 INFUSION SITE VESICLES 1 0.0019
168 MEDICAL DEVICE CHANGE 1 0.0019
169 IMPULSIVE BEHAVIOUR 7 0.0019
170 OCULOGYRIC CRISIS 4 0.0019
171 EXECUTIVE DYSFUNCTION 1 0.0018
172 HYPERTENSIVE URGENCY 1 0.0018
173 INTRACRANIAL HAEMATOMA 1 0.0018
174 DRUG EFFECT VARIABLE 2 0.0018
175 ESCHERICHIA TEST POSITIVE 2 0.0017
176 DYSMETRIA 1 0.0017
177 DISORGANISED SPEECH 3 0.0016
178 STERNAL FRACTURE 2 0.0016
179 MEDICAL DEVICE SITE INFECTION 1 0.0016
180 IMPATIENCE 3 0.0016
181 FEMORAL NECK FRACTURE 8 0.0016
182 MUCOSAL DISCOLOURATION 1 0.0016
183 INFUSION SITE IRRITATION 2 0.0016
184 DYSTONIA 30 0.0015
185 POSTURE ABNORMAL 5 0.0015
186 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
187 PSYCHOMOTOR SKILLS IMPAIRED 4 0.0015
188 LIP INJURY 2 0.0015
189 INFUSION SITE URTICARIA 1 0.0015
190 LIBIDO INCREASED 3 0.0015
191 DECUBITUS ULCER 12 0.0015
192 NASAL DISCHARGE DISCOLOURATION 2 0.0014
193 CERVICAL VERTEBRAL FRACTURE 5 0.0014
194 SUDDEN ONSET OF SLEEP 2 0.0014
195 HYPOPNOEA 5 0.0014
196 LIVEDO RETICULARIS 3 0.0014
197 INFUSION SITE SWELLING 9 0.0014
198 NASAL INJURY 1 0.0014
199 DYSLALIA 1 0.0014
200 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
201 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
202 CATHETER SITE RELATED REACTION 1 0.0013
203 CHRONIC GASTRITIS 3 0.0013
204 CHROMATOPSIA 1 0.0013
205 FACE INJURY 5 0.0013
206 ANOSMIA 19 0.0013
207 DIAPHRAGMATIC DISORDER 1 0.0013
208 PALLIATIVE CARE 2 0.0013
209 BEHAVIOUR DISORDER 7 0.0013
210 CRITICAL ILLNESS 1 0.0013
211 MEDICAL DEVICE IMPLANTATION 2 0.0013
212 INFUSION SITE PRURITUS 4 0.0013
213 EYELID FUNCTION DISORDER 1 0.0013
214 IIIRD NERVE PARALYSIS 1 0.0012
215 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
216 RESPIRATORY ALKALOSIS 2 0.0012
217 ANAL ULCER 1 0.0012
218 SHOULDER FRACTURE 2 0.0012
219 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
220 SPINAL STENOSIS 5 0.0012
221 ILLUSION 2 0.0012
222 SUFFOCATION FEELING 3 0.0012
223 PERSECUTORY DELUSION 3 0.0012
224 HYPERPARATHYROIDISM SECONDARY 3 0.0012
225 INFUSION SITE OEDEMA 1 0.0012
226 SLEEP TALKING 2 0.0012
227 MOTOR DYSFUNCTION 12 0.0012
228 ALLERGIC SINUSITIS 1 0.0012
229 DEVICE LOOSENING 1 0.0012
230 SPINAL CORD INJURY 2 0.0011
231 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
232 INFUSION SITE DISCOLOURATION 1 0.0011
233 YAWNING 3 0.0011
234 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
235 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
236 NARCOLEPSY 2 0.0011
237 THERAPEUTIC RESPONSE SHORTENED 35 0.0011
238 TRAUMATIC LUNG INJURY 2 0.0010
239 VOCAL CORD DISORDER 2 0.0010
240 EMBEDDED DEVICE 10 0.0010
241 INFUSION SITE PAIN 13 0.0010
242 ARTHRODESIS 1 0.0010
243 DEMYELINATING POLYNEUROPATHY 1 0.0010
244 CORONAVIRUS TEST POSITIVE 1 0.0010
245 IMPULSE-CONTROL DISORDER 2 0.0010
246 INFUSION SITE DISCOMFORT 1 0.0010
247 COGWHEEL RIGIDITY 1 0.0010
248 CARPAL TUNNEL DECOMPRESSION 1 0.0009
249 BLOOD SODIUM ABNORMAL 1 0.0009
250 PRODUCT DISPENSING ISSUE 4 0.0009
251 BRUXISM 5 0.0009
252 INFUSION SITE MASS 1 0.0009
253 INJECTION SITE INFECTION 3 0.0009
254 CHOKING SENSATION 5 0.0009
255 GASTROINTESTINAL ULCER 2 0.0009
256 DEMENTIA WITH LEWY BODIES 1 0.0009
257 PELVIC FRACTURE 7 0.0009
258 HYPERVENTILATION 5 0.0009
259 DEMENTIA 24 0.0009
260 HYPORESPONSIVE TO STIMULI 1 0.0009
261 JOINT DISLOCATION 9 0.0009
262 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
263 DEVICE DISPENSING ERROR 1 0.0008
264 PSYCHOTIC DISORDER 25 0.0008
265 SPUTUM DISCOLOURED 8 0.0008
266 LABILE BLOOD PRESSURE 1 0.0008
267 DEVICE DISLOCATION 36 0.0008
268 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
269 DEVICE KINK 3 0.0008
270 MOBILITY DECREASED 59 0.0008
271 DRY THROAT 8 0.0008
272 DEVICE PHYSICAL PROPERTY ISSUE 6 0.0008
273 GAIT INABILITY 26 0.0008
274 ABDOMINAL OPERATION 1 0.0008
275 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
276 ANAEMIA POSTOPERATIVE 1 0.0008
277 MALABSORPTION 4 0.0008
278 PARTIAL SEIZURES 4 0.0008
279 WALKING AID USER 5 0.0008
280 GASTROENTERITIS NOROVIRUS 1 0.0008
281 LIP EXFOLIATION 1 0.0008
282 INTESTINAL DILATATION 1 0.0007
283 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
284 INFUSION SITE RASH 1 0.0007
285 NONSPECIFIC REACTION 4 0.0007
286 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
287 PULMONARY TUBERCULOSIS 3 0.0007
288 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
289 DYSARTHRIA 26 0.0007
290 FAT TISSUE INCREASED 1 0.0007
291 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
292 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
293 WHEELCHAIR USER 3 0.0007
294 HYPERTHERMIA MALIGNANT 1 0.0007
295 DEVICE ISSUE 60 0.0007
296 SPEECH DISORDER 35 0.0007
297 HYPOSMIA 1 0.0007
298 COGNITIVE DISORDER 31 0.0007
299 HEAD INJURY 21 0.0007
300 ADHESION 1 0.0007
301 EMERGENCY CARE 2 0.0007
302 UNRESPONSIVE TO STIMULI 17 0.0007
303 DISEASE COMPLICATION 3 0.0007
304 PERSONALITY CHANGE 6 0.0006
305 FOREIGN BODY IN THROAT 2 0.0006
306 INTESTINAL OPERATION 1 0.0006
307 INTERMITTENT CLAUDICATION 1 0.0006
308 RESTLESSNESS 23 0.0006
309 GUILLAIN-BARRE SYNDROME 3 0.0006
310 DIZZINESS POSTURAL 6 0.0006
311 ASPHYXIA 5 0.0006
312 INFUSION SITE HAEMORRHAGE 2 0.0006
313 DYSGRAPHIA 4 0.0006
314 DISORIENTATION 24 0.0006
315 SALIVARY HYPERSECRETION 6 0.0006
316 GASTRIC DILATATION 1 0.0006
317 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
318 SUDDEN CARDIAC DEATH 2 0.0006
319 PRODUCT COLOUR ISSUE 3 0.0006
320 MILIARIA 1 0.0006
321 TRISMUS 3 0.0006
322 DEVICE USE ISSUE 10 0.0006
323 SERUM FERRITIN INCREASED 3 0.0006
324 PRODUCT COMMUNICATION ISSUE 5 0.0006
325 KYPHOSIS 1 0.0006
326 MITRAL VALVE DISEASE 1 0.0006
327 FEAR OF DISEASE 1 0.0006
328 INDURATION 1 0.0006
329 OBSESSIVE THOUGHTS 1 0.0006
330 PANIC REACTION 4 0.0006
331 NASAL OEDEMA 1 0.0006
332 MENTAL DISORDER 24 0.0006
333 RESTLESS LEGS SYNDROME 10 0.0005
334 APATHY 8 0.0005
335 FAECALOMA 3 0.0005
336 GAIT DISTURBANCE 104 0.0005
337 GRANULOCYTE COUNT DECREASED 1 0.0005
338 TREMOR 89 0.0005
339 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
340 ADENOCARCINOMA OF COLON 1 0.0005
341 FALL 177 0.0005
342 HYPOREFLEXIA 1 0.0005
343 AGGRESSION 26 0.0005
344 UNINTENTIONAL MEDICAL DEVICE REMOVAL 6 0.0005
345 ATRIOVENTRICULAR BLOCK 4 0.0005
346 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
347 POOR QUALITY SLEEP 11 0.0005
348 MULTI-ORGAN DISORDER 1 0.0005
349 HYPERPHAGIA 2 0.0005
350 HIP FRACTURE 16 0.0005
351 BALANCE DISORDER 43 0.0005
352 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
353 VITAMIN B12 DEFICIENCY 2 0.0005
354 DELIRIUM 17 0.0005
355 INITIAL INSOMNIA 5 0.0005
356 SCOLIOSIS 3 0.0005
357 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
358 IMPAIRED SELF-CARE 1 0.0005
359 GASTROINTESTINAL PERFORATION 2 0.0005
360 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
361 HALLUCINATIONS, MIXED 2 0.0005
362 NEUROGENIC BLADDER 1 0.0005
363 EYE CONTUSION 1 0.0005
364 INCONTINENCE 5 0.0005
365 SCREAMING 3 0.0005
366 CATHETER SITE ERYTHEMA 1 0.0005
367 INFUSION SITE BRUISING 1 0.0005
368 LANGUAGE DISORDER 1 0.0005
369 ORTHOSTATIC HYPOTENSION 8 0.0005
370 WOUND INFECTION 5 0.0005
371 ASPIRATION 5 0.0005
372 COLONOSCOPY 1 0.0005
373 HEAD DISCOMFORT 8 0.0005
374 TERMINAL STATE 3 0.0004
375 BACTERIAL TEST POSITIVE 1 0.0004
376 MALNUTRITION 5 0.0004
377 CORNEAL OEDEMA 1 0.0004
378 ANAL INCONTINENCE 4 0.0004
379 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
380 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
381 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
382 TREATMENT NONCOMPLIANCE 24 0.0004
383 LICHENOID KERATOSIS 1 0.0004
384 LUMBAR VERTEBRAL FRACTURE 2 0.0004
385 INFUSION SITE INFECTION 1 0.0004
386 HYPOPHAGIA 11 0.0004
387 CONFUSIONAL STATE 69 0.0004
388 EPILEPSY 13 0.0004
389 MYOPIA 1 0.0004
390 SEROTONIN SYNDROME 8 0.0004
391 VISUAL FIELD DEFECT 3 0.0004
392 TONGUE DISORDER 3 0.0004
393 NOCTURIA 5 0.0004
394 MUSCULOSKELETAL STIFFNESS 36 0.0004
395 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
396 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
397 INJECTION SITE ABSCESS 1 0.0004
398 GENERAL SYMPTOM 3 0.0004
399 HYPOTHERMIA 4 0.0004
400 DYSPHONIA 23 0.0004
401 ANGLE CLOSURE GLAUCOMA 1 0.0004
402 ABDOMINAL INFECTION 1 0.0004
403 CACHEXIA 2 0.0004
404 CATHETER SITE PAIN 1 0.0004
405 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
406 CATATONIA 2 0.0004
407 SENSITIVITY TO WEATHER CHANGE 2 0.0004
408 DEPRESSED MOOD 20 0.0004
409 SOPOR 5 0.0004
410 MIDDLE INSOMNIA 7 0.0004
411 AREFLEXIA 1 0.0004
412 MOVEMENT DISORDER 12 0.0004
413 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
414 ANAESTHETIC COMPLICATION 1 0.0004
415 URINARY INCONTINENCE 11 0.0004
416 GAMBLING DISORDER 1 0.0004
417 FRACTURE 7 0.0004
418 HIP SURGERY 2 0.0004
419 GASTRIC PERFORATION 1 0.0004
420 MANIA 6 0.0004
421 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
422 DEAFNESS UNILATERAL 2 0.0004
423 SOMNOLENCE 73 0.0004
424 CHOKING 7 0.0004
425 ENDOTRACHEAL INTUBATION 1 0.0004
426 AGITATION 26 0.0004
427 MICTURITION URGENCY 4 0.0003
428 DUODENAL ULCER HAEMORRHAGE 1 0.0003
429 PARANOIA 6 0.0003
430 FIBULA FRACTURE 1 0.0003
431 NIGHTMARE 12 0.0003
432 CARDIAC MURMUR 3 0.0003
433 HYPERTONIC BLADDER 1 0.0003
434 RALES 2 0.0003
435 DEVICE POWER SOURCE ISSUE 1 0.0003
436 URINE ODOUR ABNORMAL 2 0.0003
437 DECREASED INTEREST 2 0.0003
438 PRODUCT PRESCRIBING ERROR 8 0.0003
439 HYPERLIPIDAEMIA 4 0.0003
440 CEREBROVASCULAR DISORDER 1 0.0003
441 HIV INFECTION 1 0.0003
442 UNEVALUABLE EVENT 25 0.0003
443 CRANIOCEREBRAL INJURY 1 0.0003
444 INGUINAL HERNIA 2 0.0003
445 MASTICATION DISORDER 1 0.0003
446 DYSPHAGIA 31 0.0003
447 TENDON RUPTURE 4 0.0003
448 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
449 NEPHROPATHY 3 0.0003
450 LEUKAEMIA 3 0.0003
451 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
452 PHOTOPSIA 2 0.0003
453 INCOHERENT 2 0.0003
454 PARKINSONISM 3 0.0003
455 BACTERIAL SEPSIS 1 0.0003
456 HYPOVENTILATION 1 0.0003
457 BRADYPHRENIA 2 0.0003
458 LISTLESS 1 0.0003
459 LIGAMENT SPRAIN 3 0.0003
460 ABNORMAL BEHAVIOUR 12 0.0003
461 CORONAVIRUS INFECTION 2 0.0003
462 APPETITE DISORDER 2 0.0003
463 UPPER LIMB FRACTURE 6 0.0003
464 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
465 ANXIETY DISORDER 1 0.0003
466 PRODUCT ADMINISTRATION ERROR 6 0.0003
467 CLOSTRIDIAL INFECTION 1 0.0003
468 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
469 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
470 DEVICE DIFFICULT TO USE 19 0.0003
471 CAROTID ARTERY STENOSIS 1 0.0003
472 ERYTHEMA NODOSUM 1 0.0003
473 RETCHING 6 0.0003
474 PNEUMONIA ASPIRATION 7 0.0003
475 FACIAL BONES FRACTURE 1 0.0003
476 CONSTIPATION 60 0.0003
477 INTENTIONAL UNDERDOSE 2 0.0003
478 HYPOMANIA 1 0.0003
479 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
480 FOOT DEFORMITY 3 0.0003
481 HYPERTENSIVE CRISIS 3 0.0003
482 SLEEP DISORDER 19 0.0003
483 SUNBURN 2 0.0003
484 PEMPHIGOID 2 0.0003
485 AUTOIMMUNE THYROIDITIS 1 0.0003
486 CATHETER SITE INFECTION 1 0.0003
487 IMPAIRED DRIVING ABILITY 3 0.0003
488 CHOLECYSTECTOMY 3 0.0003
489 COMMUNICATION DISORDER 1 0.0003
490 CLAVICLE FRACTURE 1 0.0003
491 PROCEDURAL COMPLICATION 2 0.0003
492 DRUG INTERACTION 41 0.0003
493 BASAL CELL CARCINOMA 4 0.0003
494 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
495 PRODUCT USE COMPLAINT 4 0.0003
496 PRODUCTIVE COUGH 12 0.0003
497 CYSTITIS 8 0.0003
498 CEREBRAL ATROPHY 1 0.0003
499 OBSTRUCTION 1 0.0003
500 PRODUCT PHYSICAL ISSUE 5 0.0002
501 SPINAL OPERATION 3 0.0002
502 RIB FRACTURE 5 0.0002
503 ANXIETY 69 0.0002
504 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
505 ILEUS 3 0.0002
506 MUSCLE INJURY 2 0.0002
507 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
508 SYNCOPE 24 0.0002
509 HYPERPYREXIA 1 0.0002
510 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
511 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
512 LUNG NEOPLASM 1 0.0002
513 HORDEOLUM 1 0.0002
514 PYELONEPHRITIS 2 0.0002
515 MONOPLEGIA 1 0.0002
516 NODULE 3 0.0002
517 BEDRIDDEN 3 0.0002
518 MELANOCYTIC NAEVUS 1 0.0002
519 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
520 SARS-COV-2 TEST POSITIVE 3 0.0002
521 INTENTIONAL DEVICE MISUSE 1 0.0002
522 ABDOMINAL ABSCESS 1 0.0002
523 ILEUS PARALYTIC 1 0.0002
524 PRODUCT ADHESION ISSUE 8 0.0002
525 HAEMOLYTIC ANAEMIA 2 0.0002
526 GASTROINTESTINAL INFECTION 2 0.0002
527 IRON DEFICIENCY 1 0.0002
528 DRY MOUTH 18 0.0002
529 OROPHARYNGEAL DISCOMFORT 2 0.0002
530 IMPAIRED GASTRIC EMPTYING 3 0.0002
531 C-REACTIVE PROTEIN INCREASED 8 0.0002
532 DYSPAREUNIA 1 0.0002
533 BRAIN NEOPLASM 2 0.0002
534 EYE OPERATION 1 0.0002
535 PROCEDURAL PAIN 6 0.0002
536 NERVOUSNESS 11 0.0002
537 LIMB OPERATION 1 0.0002
538 POST PROCEDURAL COMPLICATION 4 0.0002
539 LOWER LIMB FRACTURE 4 0.0002
540 WEIGHT DECREASED 58 0.0002
541 HUMERUS FRACTURE 1 0.0002
542 PRESCRIBED OVERDOSE 4 0.0002
543 DYSSTASIA 6 0.0002
544 INCORRECT DOSAGE ADMINISTERED 1 0.0002
545 BREATH SOUNDS ABNORMAL 1 0.0002
546 HOSPICE CARE 2 0.0002
547 INFLAMMATORY MARKER INCREASED 1 0.0002
548 EXTRAPYRAMIDAL DISORDER 5 0.0002
549 BLOOD PRESSURE ABNORMAL 4 0.0002
550 ANEURYSM 1 0.0002
551 INJECTION SITE INFLAMMATION 1 0.0002
552 HYPERNATRAEMIA 1 0.0002
553 THROAT IRRITATION 9 0.0002
554 PRESCRIBED UNDERDOSE 4 0.0002
555 ERYSIPELAS 1 0.0002
556 APHASIA 6 0.0002
557 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
558 KLEBSIELLA INFECTION 1 0.0002
559 CORONARY ARTERIAL STENT INSERTION 1 0.0002
560 SLUGGISHNESS 2 0.0002
561 BLOOD PRESSURE DECREASED 13 0.0002
562 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
563 URINARY TRACT INFECTION 33 0.0002
564 DIPLOPIA 5 0.0002
565 RESPIRATORY TRACT INFECTION 5 0.0002
566 MEMORY IMPAIRMENT 26 0.0002
567 SUDDEN DEATH 2 0.0002
568 HALLUCINATION, AUDITORY 3 0.0002
569 SCIATICA 3 0.0002
570 EATING DISORDER 4 0.0002
571 SKIN CANCER 4 0.0002
572 LACTIC ACIDOSIS 6 0.0002
573 CHEILITIS 1 0.0002
574 SKIN LACERATION 2 0.0002
575 BACK INJURY 2 0.0002
576 PRODUCT DOSE OMISSION 12 0.0002
577 STAPHYLOCOCCAL INFECTION 6 0.0002
578 ABNORMAL DREAMS 5 0.0002
579 URINARY RETENTION 6 0.0002
580 BLOOD UREA INCREASED 3 0.0002
581 MACULAR OEDEMA 1 0.0002
582 ANGIOPATHY 1 0.0002
583 ACUTE PULMONARY OEDEMA 1 0.0002
584 CONDITION AGGRAVATED 54 0.0002
585 CIRCULATORY COLLAPSE 3 0.0002
586 DERMATITIS CONTACT 2 0.0002
587 NEUROLOGICAL SYMPTOM 1 0.0002
588 CARDIAC VALVE DISEASE 1 0.0002
589 COUGH 49 0.0002
590 HYPERTONIA 1 0.0002
591 EXERCISE TOLERANCE DECREASED 1 0.0002
592 MOUTH SWELLING 1 0.0002
593 DEVICE BREAKAGE 7 0.0002
594 DEPRESSION 39 0.0002
595 SPINAL PAIN 2 0.0002
596 HYPERCHLORHYDRIA 1 0.0002
597 ENERGY INCREASED 1 0.0002
598 OCULAR HYPERAEMIA 8 0.0002
599 ATAXIA 2 0.0002
600 POLYNEUROPATHY 2 0.0002
601 WRIST FRACTURE 2 0.0002
602 DRUG INTOLERANCE 16 0.0002
603 PRESYNCOPE 4 0.0002
604 ENCEPHALOPATHY 4 0.0002
605 LIMB DISCOMFORT 5 0.0002
606 FEMUR FRACTURE 5 0.0002
607 NASAL DRYNESS 1 0.0002
608 HYPOTENSION 32 0.0002
609 FOREIGN BODY SENSATION IN EYES 1 0.0002
610 GLAUCOMA 3 0.0002
611 ROTATOR CUFF SYNDROME 2 0.0002
612 CARDIAC FLUTTER 1 0.0002
613 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
614 ANGINA UNSTABLE 1 0.0002
615 FEELING ABNORMAL 36 0.0002
616 FUNGAL INFECTION 5 0.0001
617 MALIGNANT MELANOMA 2 0.0001
618 JOINT RANGE OF MOTION DECREASED 2 0.0001
619 SUICIDE ATTEMPT 9 0.0001
620 COLITIS ISCHAEMIC 1 0.0001
621 FREQUENT BOWEL MOVEMENTS 4 0.0001
622 TASTE DISORDER 3 0.0001
623 LIMB INJURY 4 0.0001
624 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
625 TACHYCARDIA 13 0.0001
626 INFARCTION 1 0.0001
627 EYE MOVEMENT DISORDER 1 0.0001
628 ECCHYMOSIS 1 0.0001
629 JOINT EFFUSION 1 0.0001
630 HAEMATOCHEZIA 8 0.0001
631 DROOLING 1 0.0001
632 HYPOGLYCAEMIA 7 0.0001
633 ORAL DISCOMFORT 2 0.0001
634 POLLAKIURIA 6 0.0001
635 CARPAL TUNNEL SYNDROME 2 0.0001
636 BLOOD TEST ABNORMAL 2 0.0001
637 BLINDNESS UNILATERAL 2 0.0001
638 DIVERTICULUM 1 0.0001
639 JOINT INJURY 3 0.0001
640 CEREBRAL HAEMORRHAGE 5 0.0001
641 DEVICE LEAKAGE 6 0.0001
642 ASTHENIA 52 0.0001
643 DERMATITIS BULLOUS 1 0.0001
644 PRODUCT DISPENSING ERROR 3 0.0001
645 CRYING 5 0.0001
646 PANIC ATTACK 5 0.0001
647 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
648 INTENTIONAL PRODUCT MISUSE 12 0.0001
649 DYSURIA 5 0.0001
650 CEREBRAL DISORDER 1 0.0001
651 FEELING DRUNK 1 0.0001
652 THERAPY NON-RESPONDER 6 0.0001
653 INTESTINAL OBSTRUCTION 5 0.0001
654 BRADYCARDIA 7 0.0001
655 PRODUCT AVAILABILITY ISSUE 3 0.0001
656 BOWEL MOVEMENT IRREGULARITY 1 0.0001
657 MUSCLE TWITCHING 3 0.0001
658 MALAISE 57 0.0001
659 THYROID DISORDER 2 0.0001
660 DECREASED APPETITE 30 0.0001
661 CONCUSSION 1 0.0001
662 VISUAL IMPAIRMENT 16 0.0001
663 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
664 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
665 NERVOUS SYSTEM DISORDER 4 0.0001
666 AFFECTIVE DISORDER 1 0.0001
667 ARRHYTHMIA 6 0.0001
668 FURUNCLE 1 0.0001
669 ULCER 2 0.0001
670 OBESITY 2 0.0001
671 DEATH 108 0.0001
672 HYPOTHYROIDISM 4 0.0001
673 BLOOD PRESSURE FLUCTUATION 3 0.0001
674 OXYGEN SATURATION DECREASED 7 0.0001
675 INSOMNIA 33 0.0001
676 FRUSTRATION TOLERANCE DECREASED 1 0.0001
677 MUSCLE DISORDER 1 0.0001
678 PERIPHERAL SWELLING 19 0.0001
679 MUSCULAR WEAKNESS 14 0.0001
680 BACK DISORDER 2 0.0001
681 DIZZINESS 61 0.0001
682 ABNORMAL FAECES 1 0.0001
683 HICCUPS 1 0.0001
684 ESCHERICHIA INFECTION 1 0.0001
685 PHOTOSENSITIVITY REACTION 2 0.0001
686 DRUG LEVEL INCREASED 2 0.0001
687 EOSINOPHIL COUNT INCREASED 1 0.0001
688 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
689 HEMIPARESIS 2 0.0001
690 HYSTERECTOMY 1 0.0001
691 DEVICE DEFECTIVE 2 0.0001
692 DEVICE USE ERROR 4 0.0001
693 VERTIGO 7 0.0001
694 DISCOMFORT 7 0.0001
695 JOINT STIFFNESS 3 0.0001
696 BLOOD CALCIUM INCREASED 1 0.0001
697 GROIN PAIN 1 0.0001
698 DISTURBANCE IN ATTENTION 6 0.0001
699 BLOOD PRESSURE INCREASED 17 0.0001
700 LOSS OF LIBIDO 1 0.0001
701 PALLOR 3 0.0001
702 LOSS OF CONSCIOUSNESS 14 0.0001
703 VISION BLURRED 15 0.0001
704 SKIN IRRITATION 5 0.0001
705 MUSCLE SPASMS 20 0.0001
706 RESPIRATORY ARREST 3 0.0001
707 WOUND 3 0.0001
708 BACTERIAL INFECTION 2 0.0001
709 DEFORMITY 1 0.0001
710 LACERATION 1 0.0001
711 BLOOD SODIUM DECREASED 2 0.0001
712 FATIGUE 82 0.0001
713 HAEMATOTOXICITY 1 0.0001
714 INTENTIONAL DOSE OMISSION 3 0.0001
715 SLEEP APNOEA SYNDROME 2 0.0001
716 ANGINA PECTORIS 3 0.0001
717 LETHARGY 6 0.0001
718 PULMONARY FIBROSIS 2 0.0001
719 AFFECT LABILITY 1 0.0001
720 CONTUSION 10 0.0001
721 HYPERCHOLESTEROLAEMIA 1 0.0001
722 HERNIA 2 0.0001
723 KNEE OPERATION 1 0.0001
724 DYSPEPSIA 10 0.0001
725 HYPERHIDROSIS 13 0.0001
726 INABILITY TO AFFORD MEDICATION 1 0.0001
727 RESPIRATORY DISORDER 3 0.0001
728 HYPOTONIA 1 0.0001
729 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
730 IRRITABILITY 6 0.0001
731 BRAIN INJURY 1 0.0001
732 ILL-DEFINED DISORDER 6 0.0001
733 FEEDING DISORDER 2 0.0001
734 EYELID PTOSIS 1 0.0001
735 DRUG LEVEL DECREASED 1 0.0001
736 BLINDNESS 4 0.0001
737 THERAPY INTERRUPTED 7 0.0001
738 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
739 HELICOBACTER INFECTION 1 0.0001
740 RHABDOMYOLYSIS 4 0.0001
741 UNDERDOSE 7 0.0001
742 PNEUMONIA 31 0.0001
743 SEIZURE 11 0.0001
744 FULL BLOOD COUNT ABNORMAL 1 0.0001
745 HYPERTENSION 20 0.0001
746 INTENTIONAL OVERDOSE 6 0.0001
747 NIGHT SWEATS 3 0.0001
748 ATRIAL FIBRILLATION 9 0.0001
749 AMNESIA 6 0.0001
750 PRODUCT PRESCRIBING ISSUE 2 0.0001
751 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
752 EYE DISORDER 3 0.0001
753 SEPSIS 10 0.0001
754 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
755 CHROMATURIA 2 0.0001
756 PRODUCT DOSE OMISSION ISSUE 26 0.0001
757 ILLNESS 9 0.0001
758 MYOCARDITIS 1 0.0001
759 NAUSEA 69 0.0001
760 SKIN DISCOLOURATION 4 0.0001
761 METASTASES TO LUNG 1 0.0001
762 PERICARDIAL EFFUSION 2 0.0001
763 BLOOD CHOLESTEROL INCREASED 4 0.0001
764 HEART RATE DECREASED 3 0.0001
765 SURGERY 5 0.0001
766 CARDIAC ARREST 7 0.0001
767 COVID-19 PNEUMONIA 1 0.0001
768 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
769 BACTERAEMIA 1 0.0001
770 CATARACT 5 0.0001
771 MYOCLONUS 1 0.0001
772 ACCIDENT 1 0.0001
773 RENAL IMPAIRMENT 7 0.0001
774 MENTAL IMPAIRMENT 2 0.0001
775 ADRENAL INSUFFICIENCY 1 0.0001
776 PAIN IN EXTREMITY 24 0.0001
777 MUSCLE SPASTICITY 1 0.0001
778 CARDIOMEGALY 1 0.0001
779 HYPERCALCAEMIA 1 0.0001
780 AGEUSIA 2 0.0001
781 PRODUCT USE ISSUE 15 0.0001
782 CELLULITIS 4 0.0001
783 HOSPITALISATION 12 0.0001
784 ABDOMINAL PAIN 18 0.0001
785 HAEMATOMA 2 0.0001
786 INJECTION SITE INDURATION 1 0.0001
787 SUICIDAL IDEATION 7 0.0001
788 SEDATION 2 0.0001
789 DEHYDRATION 10 0.0001
790 CARDIAC FAILURE 6 0.0001
791 FEAR 2 0.0001
792 EXTRA DOSE ADMINISTERED 3 0.0001
793 OEDEMA PERIPHERAL 9 0.0001
794 DRUG INEFFECTIVE 95 0.0001
795 FEELING COLD 2 0.0001
796 APHONIA 1 0.0001
797 OSTEOARTHRITIS 3 0.0001
798 HEART RATE INCREASED 7 0.0001
799 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
800 PAIN IN JAW 2 0.0001
801 FLATULENCE 4 0.0001
802 HYPERSOMNIA 2 0.0001
803 IMPAIRED QUALITY OF LIFE 1 0.0001
804 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
805 ACUTE MYOCARDIAL INFARCTION 2 0.0001
806 LABORATORY TEST ABNORMAL 2 0.0001
807 PULMONARY OEDEMA 3 0.0001
808 ADVERSE DRUG REACTION 6 0.0001
809 HYPOAESTHESIA ORAL 1 0.0001
810 LACRIMATION INCREASED 2 0.0001
811 VOMITING 31 0.0001
812 INSURANCE ISSUE 1 0.0001
813 TINNITUS 3 0.0001
814 HIP ARTHROPLASTY 1 0.0001
815 FEELING HOT 4 0.0001
816 CEREBROVASCULAR ACCIDENT 11 0.0001
817 LYMPHOMA 1 0.0001
818 MUSCULOSKELETAL CHEST PAIN 1 0.0001
819 SWOLLEN TONGUE 2 0.0001
820 BRAIN FOG 1 0.0001
821 DRUG-INDUCED LIVER INJURY 2 0.0001
822 CYANOSIS 1 0.0001
823 RHINORRHOEA 4 0.0001
824 MUSCLE TIGHTNESS 1 0.0001
825 INCORRECT DOSE ADMINISTERED 14 0.0001
826 BLOOD CREATININE INCREASED 4 0.0001
827 LUNG DISORDER 3 0.0001
828 METASTASES TO BONE 1 0.0001
829 LIP SWELLING 2 0.0001
830 CANDIDA INFECTION 1 0.0001
831 ANGER 2 0.0001
832 HAEMATURIA 2 0.0001
833 INFLAMMATION 3 0.0001
834 MUSCULOSKELETAL DISCOMFORT 1 0.0001
835 PYREXIA 20 0.0001
836 MYOCARDIAL INFARCTION 10 0.0001
837 EOSINOPHILIA 1 0.0001
838 HYPERKALAEMIA 2 0.0001
839 COVID-19 10 0.0001
840 PANCREATITIS 3 0.0001
841 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
842 DYSPNOEA 32 0.0001
843 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
844 GASTROENTERITIS VIRAL 1 0.0001
845 PAIN 34 0.0001
846 OEDEMA 3 0.0001
847 ADVERSE EVENT 5 0.0001
848 BRONCHITIS 4 0.0001
849 OROPHARYNGEAL PAIN 5 0.0001
850 MEDICATION ERROR 3 0.0001
851 NECK PAIN 3 0.0001
852 ERYTHEMA 11 0.0001
853 EPISTAXIS 4 0.0001
854 HYPONATRAEMIA 3 0.0001
855 DYSPNOEA EXERTIONAL 2 0.0001
856 MYALGIA 9 0.0001
857 FOOT FRACTURE 1 0.0001
858 GASTRIC ULCER 1 0.0001
859 NEUROPATHY PERIPHERAL 5 0.0001
860 FEELING JITTERY 1 0.0001
861 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
862 HAEMORRHOIDS 1 0.0001
863 OVERDOSE 11 0.0001
864 DISABILITY 1 0.0001
865 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
866 HAEMATOCRIT DECREASED 1 0.0001
867 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
868 HAEMOGLOBIN DECREASED 5 0.0000
869 INJECTION SITE WARMTH 1 0.0000
870 ABDOMINAL PAIN UPPER 10 0.0000
871 INFECTION 7 0.0000
872 CARDIO-RESPIRATORY ARREST 2 0.0000
873 KNEE ARTHROPLASTY 1 0.0000
874 ANAEMIA 9 0.0000
875 IMPAIRED WORK ABILITY 1 0.0000
876 DEEP VEIN THROMBOSIS 3 0.0000
877 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
878 INFLUENZA 5 0.0000
879 HEART RATE IRREGULAR 1 0.0000
880 HEADACHE 27 0.0000
881 BACK PAIN 10 0.0000
882 BURNING SENSATION 3 0.0000
883 CARDIAC DISORDER 4 0.0000
884 CHILLS 5 0.0000
885 ABDOMINAL DISCOMFORT 7 0.0000
886 RESPIRATORY FAILURE 3 0.0000
887 LIVER INJURY 1 0.0000
888 HYPOAESTHESIA 6 0.0000
889 DRY EYE 2 0.0000
890 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
891 CARDIOVASCULAR DISORDER 1 0.0000
892 ERECTILE DYSFUNCTION 1 0.0000
893 ARTHRALGIA 16 0.0000
894 ABDOMINAL DISTENSION 4 0.0000
895 DRUG DOSE OMISSION BY DEVICE 3 0.0000
896 DEAFNESS 1 0.0000
897 PARAESTHESIA 6 0.0000
898 GASTRITIS 1 0.0000
899 OFF LABEL USE 33 0.0000
900 INJECTION SITE BRUISING 3 0.0000
901 EAR INFECTION 1 0.0000
902 PROSTATE CANCER 3 0.0000
903 JAUNDICE 1 0.0000
904 DRUG EFFECT DECREASED 2 0.0000
905 RASH PRURITIC 2 0.0000
906 MOOD ALTERED 1 0.0000
907 ANAPHYLACTIC REACTION 2 0.0000
908 MENTAL STATUS CHANGES 1 0.0000
909 ARTHROPATHY 2 0.0000
910 HAEMOPTYSIS 1 0.0000
911 BLISTER 2 0.0000
912 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
913 HERPES ZOSTER 2 0.0000
914 EYE IRRITATION 2 0.0000
915 LIVER FUNCTION TEST ABNORMAL 1 0.0000
916 PRODUCT STORAGE ERROR 3 0.0000
917 PALPITATIONS 4 0.0000
918 ASCITES 1 0.0000
919 BLOOD POTASSIUM DECREASED 1 0.0000
920 JOINT SWELLING 4 0.0000
921 EMOTIONAL DISTRESS 4 0.0000
922 PLEURAL EFFUSION 2 0.0000
923 EMOTIONAL DISORDER 1 0.0000
924 BREAST CANCER 3 0.0000
925 SWELLING 3 0.0000
926 PULMONARY EMBOLISM 3 0.0000
927 MOOD SWINGS 1 0.0000
928 WEIGHT INCREASED 7 0.0000
929 SWELLING FACE 2 0.0000
930 EYE PRURITUS 1 0.0000
931 FLUSHING 3 0.0000
932 GASTRIC DISORDER 1 0.0000
933 HAEMORRHAGE 3 0.0000
934 HYPOXIA 1 0.0000
935 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
936 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
937 SKIN BURNING SENSATION 2 0.0000
938 DRUG EFFECT INCOMPLETE 1 0.0000
939 HYPERGLYCAEMIA 1 0.0000
940 ACCIDENTAL OVERDOSE 1 0.0000
941 INJECTION SITE MASS 1 0.0000
942 EYE SWELLING 1 0.0000
943 HEPATIC FUNCTION ABNORMAL 1 0.0000
944 DIARRHOEA 17 0.0000
945 CHRONIC KIDNEY DISEASE 2 0.0000
946 ACUTE KIDNEY INJURY 4 0.0000
947 INJECTION SITE SWELLING 2 0.0000
948 ARTHRITIS 2 0.0000
949 DISEASE PROGRESSION 3 0.0000
950 THROMBOSIS 2 0.0000
951 INJECTION SITE ERYTHEMA 3 0.0000
952 COMPLETED SUICIDE 2 0.0000
953 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
954 TOXICITY TO VARIOUS AGENTS 4 0.0000
955 HYPOACUSIS 1 0.0000
956 GASTROINTESTINAL DISORDER 2 0.0000
957 NEPHROLITHIASIS 1 0.0000
958 NASOPHARYNGITIS 4 0.0000
959 COMA 1 0.0000
960 MIGRAINE 2 0.0000
961 PRURITUS 8 0.0000
962 INTERSTITIAL LUNG DISEASE 1 0.0000
963 LEUKOPENIA 1 0.0000
964 FLUID RETENTION 1 0.0000
965 MUSCULOSKELETAL PAIN 1 0.0000
966 RASH 8 0.0000
967 URTICARIA 3 0.0000
968 EYE PAIN 1 0.0000
969 NASAL CONGESTION 1 0.0000
970 BLADDER CANCER 1 0.0000
971 CHEST PAIN 3 0.0000
972 HYPERSENSITIVITY 3 0.0000
973 DEVICE EXPULSION 1 0.0000
974 RENAL FAILURE 2 0.0000
975 NEOPLASM MALIGNANT 1 0.0000
976 INJECTION SITE PRURITUS 1 0.0000
977 PRODUCT QUALITY ISSUE 2 0.0000
978 HEPATIC ENZYME INCREASED 1 0.0000
979 INJECTION SITE REACTION 1 0.0000
980 INJURY 1 0.0000
981 DYSGEUSIA 1 0.0000
982 HOT FLUSH 1 0.0000
983 DIABETES MELLITUS 1 0.0000
984 INJECTION SITE PAIN 4 0.0000
985 INJECTION SITE HAEMORRHAGE 1 0.0000
986 INFLUENZA LIKE ILLNESS 1 0.0000
987 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
988 DRUG WITHDRAWAL SYNDROME 1 0.0000
989 BLOOD GLUCOSE INCREASED 2 0.0000
990 ASTHMA 1 0.0000
991 NEUTROPENIA 1 0.0000
992 NO ADVERSE EVENT 1 0.0000
993 ALOPECIA 1 0.0000